Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
No Image Available

Encorafenib API Suppliers & Bulk Manufacturers

Available Forms: API (drug substance)

Available Strengths: Supplied to an in-house or pharmacopoeial specification

Reference Brands: Braftovi

Category: Active Pharmaceutical Ingredient

Encorafenib is an oral BRAF kinase inhibitor used with other targeted drugs in melanoma, colorectal and lung cancer. It is sourced by formulators, CDMOs and research teams.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Encorafenib API? List it or send an offer →

Product Description:

Encorafenib is a kinase inhibitor that targets mutated BRAF, a protein that drives uncontrolled cell growth in some tumours. It is approved with binimetinib for BRAF V600E or V600K-mutated unresectable or metastatic melanoma and for BRAF V600E-mutated metastatic non-small cell lung cancer, and with cetuximab, with or without fluorouracil-based chemotherapy, for BRAF V600E-mutated metastatic colorectal cancer (reference brand: Braftovi).

Specification at a glance

Traded formFree base; white to almost white powder, slightly soluble at pH 1 and insoluble from pH 3 upwards
CAS number1269440-17-6
Molecular formulaC22H27ClFN7O4S
Molecular weight540.0 g/mol
PharmacopoeiaNo USP monograph yet: USP's small-molecule priority list (April 2024) names encorafenib as a candidate for a new monograph. No Ph. Eur., JP, BP or IP monograph found (unverified). Supplied to an in-house specification.

Regulatory files and timing

The FDA list of Drug Master Files (third quarter 2026) shows 3 active Type II API DMFs for this molecule. Few filings usually means few qualified sources, so early contact with suppliers pays off. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.

Generic or biosimilar entry. United States: Patent expiry; entry not confirmed (2030 (2031 with pending PTE)). European Union: No confirmed date.

Handling and quality points

Encorafenib's solubility drops sharply as pH rises, so particle size and solid form should be agreed with the formulator because both affect dissolution. The molecule has one stereocentre in its side chain, so chiral purity belongs in the specification. Treat it as a potent anticancer compound and expect suppliers to provide containment and cleaning data, together with nitrosamine and mutagenic impurity assessments.

Send an API enquiry All specialty APIs

Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.

Encorafenib API — third party manufacturing & bulk supply

Encorafenib API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Encorafenib API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Encorafenib API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Encorafenib API →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Ask for the GMP certificate, certificate of analysis and specification first. A US DMF letter of access, or an EU ASMF where one exists, will be needed for filings. Buyers also look for chiral purity data, a nitrosamine risk assessment and stability results covering the proposed retest period.

Because it is barely soluble above pH 2, small changes in crystal form or particle size can change dissolution. Ask which form the supplier makes, how it is confirmed (usually XRPD) and whether it stays stable on storage, and set a particle size limit that suits your capsule process.

Yes. PharmaTradz links licensed manufacturers, CDMOs and R&D teams to GMP-compliant encorafenib makers and reviews the paperwork before introductions. Your company stays anonymous until both sides decide to talk.

Related Products

Venetoclax API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Venclexta, Venclyxto

View Details
Ozanimod Hydrochloride API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Zeposia

View Details
Pasireotide API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Signifor, Signifor LAR

View Details
Relugolix API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Orgovyx, Myfembree, Ryeqo

View Details
Calcium Dobesilate Granules

Strength:
API Purity: 98% (on anhydrous basis)

Form: Granules/ Powder

Reference Brands:

View Details
Isavuconazole

Strength:
High-purity API

Form: White to off-white crystalline powder

Reference Brands: Cresemba (US/EU)

View Details
Levocarnitine API

Strength:
API Purity: 98% (on anhydrous basis) BP / EP / USP Standard

Form: Crystalline powder

Reference Brands: Carnitor (US/EU)

View Details
Doxepin

Strength:
API Purity: 99% (on anhydrous basis)

Form: White to off-white crystalline powder

Reference Brands: Sinequan, Silenor (US)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us